Locations and Appointments
Insurances Accepted
Before your appointment, please contact the doctor's office or your insurance provider to verify that your insurance is accepted. This list of insurances can change, and the insurance plans listed may not be accepted at all office locations for this provider.
- Aetna Signature Administrators
- Medicare Managed Care
- HMO
- PPO
- POS
- EPO
- NY Signature
- Student Health
- Essential Plan
- Medicaid Managed Care
- Special Needs
- Medicare Managed Care
- PPO
- HMO
- Great West (National)
- EPO
- POS
- PPO
- Medicare Managed Care
- Select Care (Exchange)
- Vytra
- EPO
- Medicare Managed Care
- HMO
- PPO
- POS
- ConnectiCare
- Essential Plan
- Medicaid Managed Care
- Medicaid Managed Care
- Child/Family Health Plus
- Essential Plan
- PPO
- Medicare Managed Care
- HMO
- EPO
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Child/Family Health Plus
- Medicare Managed Care
- Local 1199
- MagnaCare
- Traditional Medicare
- Railroad
- Multiplan
- HMO
- Essential Plan
- Child/Family Health Plus
- Medicaid Managed Care
- Special Needs
- HMO
- POS
- PPO
- Columbia University Employee Plan
- Empire Plan
- Compass (Exchange)
- Oxford Liberty
- Oxford Freedom
- Oxford HMO
- Medicare Managed Care
- Medicaid (Community Plan)
- SelectHealth
- Medicare Managed Care
- Special Needs
- Medicaid Managed Care
- Medicare Managed Care
- World Trade Center Health Plan
About Timothy C Wang, MD
Dr. Timothy Wang is a leading expert in gastroenterology cancer research and patient care. His research specifically focuses on transgenic/ knockout mice, stem cells, lineage tracing, bone marrow-derived cells, and FACS analysis of immune/epithelial cells in the gut. His laboratory has for decades investigated the molecular mechanisms of gastrointestinal carcinogenesis, and has been continuously funded by the NIH for 29 years and by the NCI for 14 years. His lab has worked for many years on the role of inflammation in promoting gastrointestinal neoplasia, including colon cancer. His research has defined key roles for stromal cells in tumor development, including myeloid cells.
Dr. Wang serves as Co-leader of the Tumor Biology and Microenvironment Program of the Herbert Irving Comprehensive Cancer Center. He also serves as director of the Columbia University NCI U54 Tumor Microenvironment (TMEN) program and directs the Barrett's Esophageal Translational Research Network (BETRNet) program and the Intestinal Stem Cell Consortium (ISCC) at Columbia.
In addition to his leadership at Columbia, Dr. Wang has served as President of the American Gastroenterology Association (AGA). His work has been recognized with numerous awards, including the Outstanding Investigator Award from the NCI, the Irene and Arthur Fishberg Prize for medical research, the Ruth Leff Siegel Award for pancreatic cancer research, and the William Beaumont Prize in Gastroenterology from the AGA. Over his career, he has organized numerous conferences, including conferences on Gastrin, Regulatory Peptides, AACR Symposium on Gastric Cancer, Tumor Microenvironment, and Keystone Conferences.
Board Certifications
Specialties & Expertise
EDUCATION
- Internship: Barnes Jewish Hospital
- Residency: Barnes Jewish Hospital
- Fellowship: Harvard Hospitals
LEADERSHIP, TITLES & POSITIONS
- Dorothy L. and Daniel H. Silberberg Professor of Medicine
- Co-Director, Tumor Biology and Microenvironment Program, Herbert Irving Comprehensive Cancer Center
- Director, GI/Pancreas Program in Development, Herbert Irving Comprehensive Cancer Center
HOSPITAL AFFILIATIONS
- NewYork-Presbyterian / Columbia University Irving Medical Center




